中药砒霜上调E-钙黏蛋白抑制宫颈癌Hela 细胞生长、侵袭、迁移机制研究
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R737.33

基金项目:

广东省中医药局面上项目(20211139);广东省中医药局面上项目(20222051)


Study on Mechanism of Arsenic Up-Regulating E-Cadherin to Inhibit Growth, Invasion and Migration of Cervical Cancer Hela Cells
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:研究中药砒霜的主要成分三氧化二砷(As2O3) 抑制宫颈癌Hela细胞生长、侵袭、迁移的机 制,观察As2O3对宫颈癌Hela细胞组蛋白脱乙酰基酶1(HDAC1)、E-钙黏蛋白表达的影响,以及联合HDAC1 抑制剂伏立诺他(SAHA) 的协同作用。方法:以宫颈癌Hela细胞作为载体,随机分为空白对照组、As2O3组、 SAHA组、As2O3+SAHA组4组,采用CCK-8法测定不同药物浓度对Hela细胞活性的抑制情况,并筛选后续实 验药物浓度;采用Transwell法、划痕法检测各组药物对Hela细胞侵袭、迁移能力的影响;采用实时荧光定量 聚合酶链式反应及蛋白免疫印迹法检测HDAC1和E-钙黏蛋白的mRNA表达情况与蛋白表达情况。结果:随着 各组药物浓度增加,Hela细胞的活性逐渐降低。As2O3组、SAHA组、As2O3+SAHA组的Hela细胞活性均低于空 白对照组(P<0.05)。As2O3 组、SAHA 组、As2O3+SAHA 组穿越Transwell小室膜的细胞数量均少于空白对照 组(P<0.05);As2O3+SAHA组的细胞数量少于As2O3组、SAHA组(P<0.05);As2O3组的细胞数量少于SAHA 组(P<0.05)。As2O3 组、SAHA 组、As2O3+SAHA 组的Hela 细胞迁移百分比均低于空白对照组(P<0.05); As2O3+SAHA组的Hela细胞迁移百分比低于As2O3组、SAHA组(P<0.05);As2O3组的Hela细胞迁移百分比低于 SAHA组(P<0.05)。As2O3组、SAHA组、As2O3+SAHA组的HDAC1 mRNA表达水平均低于空白对照组(P< 0.05);As2O3组的HDAC1 mRNA表达水平高于SAHA组(P<0.05);As2O3+SAHA组的HDAC1 mRNA表达水平 低于As2O3组、SAHA组(P<0.05)。As2O3组、SAHA组、As2O3+SAHA组的E-钙黏蛋白mRNA表达水平均高于 空白对照组(P<0.05);As2O3+SAHA 组的E-钙黏蛋白mRNA 表达水平高于As2O3 组、SAHA 组(P<0.05)。 As2O3组、SAHA组、As2O3+SAHA组的HDAC1蛋白表达水平均低于空白对照组(P<0.05);As2O3+SAHA组的 HDAC1蛋白表达水平低于As2O3组、SAHA组(P<0.05)。As2O3组、SAHA组、As2O3+SAHA组E-钙黏蛋白的蛋 白表达水平均高于空白对照组(P<0.05);As2O3+SAHA组E-钙黏蛋白的蛋白表达水平高于As2O3组、SAHA 组(P<0.05)。结论:As2O3抑制Hela细胞的最佳浓度为8 μmol/L,联合SAHA时,最佳抑制浓度为4 μmol/L。 As2O3可能通过抑制HDAC1的表达,同时促进升高E-钙黏蛋白的表达,与SAHA发挥协同作用抑制Hela细胞生 长、侵袭、迁移。

    Abstract:

    Abstract:Objective:To investigate the mechanism of arsenic trioxide (As2O3),the main component of Arsenic (Chinese medicine),inhibiting the growth,invasion and migration of Hela cells of cervical cancer, and to observe the effects of As2O3 on the expression of histone deacetylase 1 (HDAC1) and E-cadherin in Hela cells of cervical cancer, and the synergistic effect of HDAC1 inhibitor Vorinostat (SAHA). Methods: The oncomine database was used to investigate the expression differences of CDH1 gene in cervical cancer tissues with and without distant metastasis. Cervical cancer Hela cells were used as carriers, and were randomly divided into four groups: the blank control group, the As2O3 group, the SAHA group and the As2O3+SAHA group. CCK-8 method was used to determine the inhibition of different drug concentrations on Hela cell growth, and the subsequent experimental drug concentrations were screened; Transwell method and scratch method were used to detect the effects of various medicine on invasion and migration ability of Hela cells; real-time fluorescence quantitative polymerase chain reaction and protein Western blotting methods were used to detect the protein and mRNA expression of HDAC1 and E-cadherin. Results: The Hela cell activity gradually decreased with the increasing drug concentration in each group. The Hela cell activity in the As2O3 group,the SAHA group and the As2O3+SAHA group were all lower than that in the blank control group (P<0.05). The numbers of cells crossing the Transwell chamber membrane in the As2O3group, the SAHA group and the As2O3+SAHA group were all lower than that in the blank control group (P<0.05); the number of cells in the As2O3+SAHA group was lower than those in the As2O3 group and the SAHA group (P<0.05); the number of cells in the As2O3 group was lower than that in the SAHA group (P<0.05). The percentages of migration of Hela cells in the As2O3 group, the SAHA group and the As2O3+SAHA group were lower than that in the blank control group (P<0.05);the percentage of migration of Hela cells in the As2O3+SAHA group was lower than those in the As2O3 group and the SAHA group (P<0.05); the percentage of migration of Hela cells in the As2O3 group was lower than that in the SAHA group (P<0.05). The HDAC1 mRNA expression levels in the As2O3 group,the SAHA group and the As2O3+SAHA group were lower than that in the blank control group (P<0.05);the HDAC1 mRNA expression level in the As2O3 group was higher than that in the SAHA group (P<0.05); the level in the As2O3+SAHA group was lower than those in the As2O3 group and the SAHA group (P<0.05). The mRNA expression levels of E-cadherin in the As2O3 group, the SAHA group, and the As2O3+SAHA group were all higher than that in the blank control group (P<0.05);the mRNA expression level of E-cadherin in the As2O3+SAHA group was higher than that in the As2O3 group and the SAHA group (P<0.05). The HDAC1 protein expression levels in the As2O3 group, the SAHA group and the As2O3+SAHA group were lower than that in the blank control group (P<0.05);the HDAC1 protein expression level in the As2O3+SAHA group was lower than those in the As2O3 group and the SAHA group (P<0.05). The E-cadherin protein expression levels in the As2O3 group,the SAHA group and the As2O3+SAHA group were higher than that in the blank control group (P<0.05);the E-cadherin protein expression level in the As2O3+SAHA group was higher than those in the As2O3 group and the SAHA group (P<0.05). Conclusion: The optimal concentration of As2O3 to inhibit Hela cells is 8 μmol/L, and when combined with SAHA,the optimal inhibitory concentration is 4 μmol/L. As2O3 can inhibit the expression of HDAC1, promote the expression of E-cadherin, and play a synergistic role with SAHA to inhibit the growth,invasion and migration of Hela cells.

    参考文献
    相似文献
    引证文献
引用本文

李思瑾,李海盈,何泽阳,李安,张亚文,李道成.中药砒霜上调E-钙黏蛋白抑制宫颈癌Hela 细胞生长、侵袭、迁移机制研究[J].新中医,2024,56(14):145-152

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2024-07-28
  • 出版日期:
文章二维码